• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮针刀筋膜切开术治疗杜普伊特伦挛缩:一项基于登记的、观察性队列研究,涉及 2257 例患者的 3331 个治疗手指的并发症。

Percutaneous needle fasciotomy in Dupuytren contracture: a register-based, observational cohort study on complications in 3,331 treated fingers in 2,257 patients.

机构信息

Elective Surgery Centre, Silkeborg Regional Hospital, Denmark.

Department of Orthopaedic Surgery, Horsens Regional Hospital, Denmark.

出版信息

Acta Orthop. 2020 Jun;91(3):326-330. doi: 10.1080/17453674.2020.1726057. Epub 2020 Feb 14.

DOI:10.1080/17453674.2020.1726057
PMID:32056475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8023958/
Abstract

Background and purpose - Percutaneous needle fasciotomy (PNF) is a minimally invasive treatment option for Dupuytren contracture, which has gained momentum worldwide in recent years. However, evidence regarding safety and severe complications associated with PNF is sparse. Thus, we evaluated safety of a specific PNF method in the largest cohort reported in literature.Patients and methods - This is a single-center, register-based, observational study on PNF treatments between 2007 and 2015. The study cohort was identified by the Danish National Patient Registry, and diagnosis codes and procedure codes were used to identify potential severe postoperative complications such as: tendon rupture, nerve damage, infection, amputation, and reflex dystrophy for all index treatments. The Danish National Prescription Registry was used to identify non-hospital-treated infections. All index treatments and postoperative complications were verified by review of medical records.Results - 2,257 patients received PNF treatment of 3,331 treated finger rays. Median follow-up was 7.2 years (interquartile range: 4.9-9.5 years, range 1-12 years). 4 patients sustained flexor tendon rupture. 1 patient had digital nerve damage. 2 patients had an infection treated in hospital, while 31 patients received antibiotics in the primary sector for an infection or based on suspicion of an infection after PNF. None of the infections required surgical intervention. No finger amputations or ipsilateral upper limb reflex dystrophy cases were registered in relation to the procedure.Interpretation - Percutaneous needle fasciotomy for Dupuytren contracture is a safe procedure with a low rate of severe postoperative complications when a specific PNF method is applied.

摘要

背景与目的 - 经皮针刀松解术(PNF)是一种治疗掌腱膜挛缩症的微创治疗选择,近年来在全球范围内得到了广泛的应用。然而,关于 PNF 相关安全性和严重并发症的证据仍然很少。因此,我们评估了在文献报道的最大队列中,一种特定的 PNF 方法的安全性。

患者和方法 - 这是一项单中心、基于注册的、观察性研究,研究对象为 2007 年至 2015 年期间接受 PNF 治疗的患者。研究队列通过丹麦国家患者登记处确定,使用诊断代码和手术代码来识别所有索引治疗的潜在严重术后并发症,如:肌腱断裂、神经损伤、感染、截肢和反射性营养不良。丹麦国家处方登记处用于识别非医院治疗的感染。所有索引治疗和术后并发症均通过查阅病历进行验证。

结果 - 2257 例患者接受了 3331 个治疗手指射线的 PNF 治疗。中位随访时间为 7.2 年(四分位间距:4.9-9.5 年,范围 1-12 年)。4 例患者发生屈肌腱断裂,1 例患者发生指神经损伤。2 例患者发生医院治疗的感染,而 31 例患者在 PNF 后因感染或疑似感染在初级保健部门接受了抗生素治疗。没有感染需要手术干预。与该手术相关,未记录到手指截肢或同侧上肢反射性营养不良病例。

结论 - 当应用特定的 PNF 方法时,经皮针刀松解术治疗掌腱膜挛缩症是一种安全的手术,其严重术后并发症发生率较低。

相似文献

1
Percutaneous needle fasciotomy in Dupuytren contracture: a register-based, observational cohort study on complications in 3,331 treated fingers in 2,257 patients.经皮针刀筋膜切开术治疗杜普伊特伦挛缩:一项基于登记的、观察性队列研究,涉及 2257 例患者的 3331 个治疗手指的并发症。
Acta Orthop. 2020 Jun;91(3):326-330. doi: 10.1080/17453674.2020.1726057. Epub 2020 Feb 14.
2
[The Extended Percutaneous Needle Fasciotomy Technique (PNF+) For Dupuytren's Contracture].[用于掌腱膜挛缩症的改良经皮针状筋膜切开术技术(PNF+)]
Handchir Mikrochir Plast Chir. 2017 Feb;49(1):47-50. doi: 10.1055/s-0043-102687. Epub 2017 Apr 19.
3
Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.杜普伊特伦挛缩症:经皮针状筋膜切开术与开放性筋膜切除术的疗效分析
ANZ J Surg. 2015 Sep;85(9):639-43. doi: 10.1111/ans.12513. Epub 2014 Jan 20.
4
Percutaneous needle fasciotomy for recurrent Dupuytren disease.经皮针状筋膜切开术治疗复发性杜普伊特伦挛缩病
J Hand Surg Am. 2012 Sep;37(9):1820-3. doi: 10.1016/j.jhsa.2012.05.022. Epub 2012 Jul 3.
5
Early Postoperative Results of Percutaneous Needle Fasciotomy in 451 Patients with Dupuytren Disease.451例掌腱膜挛缩症患者经皮针状筋膜切开术的术后早期结果
Plast Reconstr Surg. 2017 Jun;139(6):1415-1421. doi: 10.1097/PRS.0000000000003357.
6
Analysis of recurrence and complications after percutaneous needle fasciotomy in Dupuytren's disease.掌腱膜挛缩症经皮针刀松解术后复发及并发症分析。
Arch Orthop Trauma Surg. 2019 Oct;139(10):1471-1477. doi: 10.1007/s00402-019-03247-y. Epub 2019 Jul 31.
7
Challenges and innovations in the surgical treatment of advanced Dupuytren disease by percutaneous needle fasciotomy: indications, limitations, and medico-legal implications.经皮针刀筋膜切开术治疗晚期掌腱膜挛缩症的挑战与创新:适应证、局限性及医学法律影响。
J Orthop Surg Res. 2024 Jul 23;19(1):424. doi: 10.1186/s13018-024-04844-3.
8
Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.注射用胶原酶与经皮针状筋膜切开术治疗近端指间关节掌腱膜挛缩症的随机对照试验
J Hand Surg Am. 2017 May;42(5):321-328.e3. doi: 10.1016/j.jhsa.2017.03.003.
9
A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease.经皮针状筋膜切开术与胶原酶注射治疗掌腱膜挛缩症的比较
J Hand Surg Am. 2013 Dec;38(12):2377-80. doi: 10.1016/j.jhsa.2013.08.096. Epub 2013 Sep 20.
10
[Medium-term Results after percutaneous Needle Fasciotomy in Dupuytren's Disease].[经皮针状筋膜切开术治疗掌腱膜挛缩症的中期结果]
Handchir Mikrochir Plast Chir. 2023 Sep;55(5):330-335. doi: 10.1055/a-2055-1592. Epub 2023 Jul 10.

引用本文的文献

1
Dupuytren's Disease Percutaneous Needle Aponeurotomy: Does Grip Strength Improve Post Procedure?掌腱膜挛缩症的经皮针状腱膜切开术:术后握力会改善吗?
J Clin Med. 2025 Jun 12;14(12):4171. doi: 10.3390/jcm14124171.
2
Modified percutaneous needle aponeurotomy for Dupuytren's disease: case series with functional outcome.改良经皮针腱膜切开术治疗掌腱膜挛缩症:功能结果的病例系列研究
Musculoskelet Surg. 2025 Mar 31. doi: 10.1007/s12306-025-00899-5.
3
[Medium-term Results after percutaneous Needle Fasciotomy in Dupuytren's Disease].[经皮针状筋膜切开术治疗掌腱膜挛缩症的中期结果]
Handchir Mikrochir Plast Chir. 2023 Sep;55(5):330-335. doi: 10.1055/a-2055-1592. Epub 2023 Jul 10.
4
Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.《掌腱膜挛缩症的外科治疗:系统评价和网络荟萃分析》。
Hand (N Y). 2024 Nov;19(8):1283-1292. doi: 10.1177/15589447231174175. Epub 2023 May 28.
5
Treatment Options for Dupuytren's Disease: Tips and Tricks.掌腱膜挛缩症的治疗选择:技巧与窍门
Plast Reconstr Surg Glob Open. 2022 Jan 27;10(1):e4046. doi: 10.1097/GOX.0000000000004046. eCollection 2022 Jan.
6
Dupuytren's Disease-Etiology and Treatment.杜普伊特伦挛缩症-病因与治疗。
Dtsch Arztebl Int. 2021 Nov 19;118(46):781-788. doi: 10.3238/arztebl.m2021.0325.
7
Versatility of percutaneous needle fasciotomy for Dupuytren's disease across a spectrum of disease severity: A single-surgeon experience of 118 rays.经皮针状筋膜切开术治疗不同严重程度杜普伊特伦挛缩症的多功能性:一位外科医生对118根手指的治疗经验
JPRAS Open. 2020 Nov 30;27:80-89. doi: 10.1016/j.jpra.2020.11.008. eCollection 2021 Mar.
8
Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19.经皮针状筋膜切开术治疗掌腱膜挛缩症:一种适用于 COVID-19 时代的一站式方法。
J Plast Reconstr Aesthet Surg. 2020 Nov;73(11):2086-2102. doi: 10.1016/j.bjps.2020.08.037. Epub 2020 Aug 29.

本文引用的文献

1
Needle Aponeurotomy for Dupuytren Disease.用于掌腱膜挛缩症的针刀腱膜切开术
Hand Clin. 2018 Aug;34(3):331-344. doi: 10.1016/j.hcl.2018.03.003.
2
Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.经皮针刀松解术与胶原酶治疗掌腱膜挛缩症的随机对照试验:一项为期两年的随访研究。
J Bone Joint Surg Am. 2018 Jul 5;100(13):1079-1086. doi: 10.2106/JBJS.17.01128.
3
Variation in Treatment Recommendations for Dupuytren Disease.杜普伊特伦挛缩病治疗建议的差异
J Hand Surg Am. 2017 Dec;42(12):963-970.e6. doi: 10.1016/j.jhsa.2017.08.023. Epub 2017 Sep 23.
4
Complications after treating Dupuytren's disease. A systematic literature review.掌腱膜挛缩症治疗后的并发症。一项系统的文献综述。
Hand Surg Rehabil. 2017 Oct;36(5):322-329. doi: 10.1016/j.hansur.2017.07.002. Epub 2017 Sep 14.
5
Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.注射用胶原酶与经皮针状筋膜切开术治疗近端指间关节掌腱膜挛缩症的随机对照试验
J Hand Surg Am. 2017 May;42(5):321-328.e3. doi: 10.1016/j.jhsa.2017.03.003.
6
Comparison of Treatment Outcome After Collagenase and Needle Fasciotomy for Dupuytren Contracture: A Randomized, Single-Blinded, Clinical Trial With a 1-Year Follow-Up.胶原酶与针刀筋膜切开术治疗掌腱膜挛缩症的疗效比较:一项为期1年随访的随机、单盲临床试验
J Hand Surg Am. 2016 Sep;41(9):873-80. doi: 10.1016/j.jhsa.2016.06.014. Epub 2016 Jul 27.
7
One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.针式筋膜切开术与胶原酶注射治疗掌腱膜挛缩症的一年期结果:一项双中心前瞻性随机临床试验
J Hand Surg Eur Vol. 2016 Jul;41(6):577-82. doi: 10.1177/1753193415617385. Epub 2015 Dec 1.
8
Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.掌腱膜挛缩症管理的成本效益。加拿大当前和未来管理策略的成本效益分析。
Bone Joint J. 2013 Aug;95-B(8):1094-100. doi: 10.1302/0301-620X.95B8.31822.
9
The impact of Dupuytren disease on patient activity and quality of life.掌腱膜挛缩症对患者活动及生活质量的影响。
J Hand Surg Am. 2013 Jun;38(6):1209-14. doi: 10.1016/j.jhsa.2013.03.036.
10
Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.开放性部分筋膜切除术、经皮腱膜切开术和胶原酶注射治疗掌腱膜挛缩症的成本效益分析
J Hand Surg Am. 2011 Nov;36(11):1826-1834.e32. doi: 10.1016/j.jhsa.2011.08.004. Epub 2011 Oct 5.